Status:
COMPLETED
Cognitive Behavioral Therapy (CBT) for Nightmares in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans
Lead Sponsor:
VA Office of Research and Development
Conditions:
Posttraumatic Stress Disorder
Sleep Disorders
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the effectiveness of two talk therapies for OEF/OIF Veterans at the Michael J. Crescenz and the West Haven VA Medical Centers. Participants will randomly receiv...
Detailed Description
This is a dismantling study with the objective of determining whether imagery rehearsal is essential to the efficacy of imagery rehearsal + CBT-I for improving the sleep and nightmare disturbance in V...
Eligibility Criteria
Inclusion
- Currently enrolled in treatment in the Michael J. Crescenz VA Medical Center or VA Connecticut Healthcare System Mental Health Clinic
- Meets DSM-IV-R criteria for current PTSD (within the past month)
- Repetitive, military-related nightmares (at least 1 every 2 weeks, for at least 6 months)
- A global sleep disturbance, as indicated by a score of five or greater on the Pittsburgh Sleep Quality Index
- Ability to read and speak English
- A concurrent anxiety disorder or depressive disorder diagnosis will be allowed
- Dementia related to head injury and amnestic disorder related to head injury will be allowed
Exclusion
- Current substance dependence
- Bipolar disorder
- Delirium
- Dementia that is not related to head injury
- Amnestic disorder that is not related to head injury
- Schizophrenia and other psychotic disorders
- Severe traumatic brain injury, as indicated by self-report (loss of consciousness or alteration of mental status greater than 24 hours, or peri-traumatic memory loss, or any posttraumatic amnesia greater than 7 days)
- The presence of diagnosed sleep disorders other than insomnia: narcolepsy, circadian rhythm sleep disorders, and periodic limb movement disorder. Participants in treatment for sleep apnea, or who have not benefited from or declined available treatment may be included.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT00691626
Start Date
April 1 2009
End Date
December 31 2019
Last Update
January 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania, United States, 19104